Elsevier Inc.

SHERPA: Unknown

People

  1. Giralt
    Giralt
  2. Devlin
    Devlin
  3. Perales
    Perales
  4. Shah
    Shah
  5. Ponce
    Ponce
  6. Dahi
    Dahi
  7. Papadopoulos
    Papadopoulos
  8. Jakubowski
    Jakubowski
  9. Scordo
    Scordo
  10. Castro-Malaspina
    Castro-Malaspina

Groups

  1. Biostatistics Service (175)
  2. Epidemiology and Biostatistics (175)
  3. Department of Medicine (172)
  4. Hematologic Malignancies, Division of (172)
  5. Center for Hematologic Malignancies (171)
  6. Bone Marrow Transplant (167)
  7. Survivorship Research (135)
  8. CTCR Scholars (118)
  9. MSK Grad Students (105)
  10. Master of Science in Clinical and Translational Cancer Research (103)
Search Within
  1. "Sean Devlin"
Formats
  1. Meeting Abstract (124)
  2. Journal Article (51)
Groups
  1. Biostatistics Service (175)
  2. Epidemiology and Biostatistics (175)
  3. Department of Medicine (172)
  4. Hematologic Malignancies, Division of (172)
  5. Center for Hematologic Malignancies (171)
  6. Bone Marrow Transplant (167)

More Groups

People
  1. Sean Devlin (175)
  2. Sergio Giralt (144)
  3. Miguel-Angel Perales (110)
  4. Molly Maloy (71)
  5. Gunjan Shah (68)
  6. Juliet Barker (66)

More People

Years
  1. 2025 (4)
  2. 2024 (6)
  3. 2023 (7)
  4. 2022 (11)
  5. 2021 (6)
  6. 2020 (19)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (133)
  2. Transplantation and Cellular Therapy (25)
  3. Clinical Lymphoma, Myeloma and Leukemia (13)
  4. International Journal of Radiation Oncology, Biology, Physics (2)
  5. American Journal of Obstetrics and Gynecology (1)
  6. Contemporary Clinical Trials (1)

Results (175)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CAR and ALL hematotox scores predict toxicity and outcomes among recipients of brexucabtagene autoleucel for R/R ALL in the real world outcomes collaborative of CAR-T in adult ALL (ROCCA) consortium
    Meeting Abstract

    Valtis, Y.; Lin, C. Y.; Nemirovsky, D.; Devlin, S.; Rejeski, K.; Shah, N. N.; Nair, M. S.; Jeyakumar, N.; Miller, K.; Zhang, A.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Health-related values discussions with patients undergoing allogeneic and autologous stem cell transplant: Feasibility and acceptability of an early primary palliative care intervention
    Journal Article

    Cohen, A. G.; Cho, C.; Patterson, E.; Magaldi, J.; Doga, T.; Naputo, K.; Alvarez, K.; Giles, E.; Yang, G.; Hoque, A.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Shift from widespread to tailored antifungal prophylaxis in lymphoma patients treated with CD19 CAR T cell therapy: Results from a large retrospective cohort
    Journal Article

    Melica, G.; Luna de Abia, A.; Shah, G. L.; Devlin, S.; Corona, M.; Fein, J.; Dahi, P. B.; Giralt, S. A.; Lin, R. J.; Palomba, M. L.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Influence of obesity on the efficacy and toxicity of patients undergoing autologous hematopoietic cell transplantation for lymphoma
    Journal Article

    Lin, A.; Pearl, N.; Flynn, J.; Devlin, S.; Dahi, P.; Perales, M. A.; Scordo, M.; Shah, G. L.
    Clinical Lymphoma, Myeloma and Leukemia (2025)

    Fulltext@MSK | Save
  • Improvement in radiomic features following bridging therapy is prognostic for CD19 chimeric antigen receptor (CAR) T-cell therapy outcome
    Meeting Abstract

    Hubbeling, H. G.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G. L.; Fregonese, B.; Bedmutha, A.; Boardman, A.; Dahi, P. B.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Establishing a graft-versus-host disease (GVHD)-focused multidisciplinary telehealth clinic
    Journal Article

    Harris, A. C.; Markova, A.; Devlin, S.; Singh, A.; Susman, P.; Brown, S.; Grasso, C.; Custodio, C.; Estilo, C.; Ibanez, K.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Phase I trial of MCARH109, a first-in-class G Protein Coupled Receptor Class C Group 5 Member D (GPRC5D)-targeted CAR T-cell therapy for relapsed or refractory multiple myeloma: Updated analysis
    Meeting Abstract

    Jurgens, E.; Firestone, R.; Chaudhari, J.; Hosszu, K.; Devlin, S.; Shah, U.; Landa, J.; McAvoy, D.; Lesokhin, A.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Subsequent malignancies after CD19-targeted chimeric antigen receptor T cells in patients with lymphoma
    Journal Article

    Lorenc, R.; Shouval, R.; Flynn, J. R.; Devlin, S. M.; Saldia, A.; Luna De Abia, A.; De Lapuerta, M. C.; Tomas, A. A.; Cassanello, G.; Leslie, L. A.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Reduced-intensity compared to nonmyeloablative conditioning in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic stem cell transplantation
    Journal Article

    Nath, K.; Peterson, K.; Brown, S.; Devlin, S.; Rodriguez, N.; Barker, J.; Giralt, S.; Gyurkocza, B.; Jakubowski, A.; Papadopoulos, E.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Outcomes and management of the SARS-CoV2 omicron variant in recipients of hematopoietic cell transplantation and chimeric antigen receptor T cell therapy
    Journal Article

    Infante, M. S.; Nemirovsky, D.; Devlin, S.; DeWolf, S.; Tamari, R.; Dahi, P. B.; Lee, Y. J.; Chung, D. J.; Politikos, I.; Barker, J.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save